Researchers face more obstacles studying the lung microbiome than the gut microbiome. One big hurdle is collecting lung samples. In a new study, researchers used an invasive technique to collect fluid from children’s lungs and discovered how the lung’s microbial makeup affects stem cell transplant outcomes.
The company plans to develop more specialized, antibody-based GPCR drugs to treat a myriad of diseases. They recruited a leader in overseeing successful clinical trials to get the job done.
COVID-19 has gotten a little better at infecting cells and dodging antibodies with each set of mutations in new variants. Omicron is the best at dodging antibodies, but its modified structure sacrificed virulence for antibody resistance.
LIVE April 19th, 2022 at 11:30 AM Biologics targeting coronavirus and variants of interest emerge as the latest therapeutic strategy for treating COVID-19.
We’ve updated our Privacy Policy to make it clearer how we use your personal data. Please read our Cookie Policy to learn how we use cookies to provide you with a better experience.